Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL567640 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Farnesoid X receptor/Bile acid receptor FXR in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2047] [GtoPdb: 603] [UniProtKB: Q96RI1] | ||||||||
ChEMBL | Agonist activity at FXR expressed in COS1 cells by cell-based bioluminescence assay | F | 4 | pEC50 | >100000 | nM | EC50 | J Med Chem (2009) 52: 7958-7961 [PMID:20014870] |
ChEMBL | Agonist activity at GST-tagged FXR-LBD using biotinylated-SRC-1 peptide as substrate preincubated with compound for 30 mins measured after 4 hrs | F | 4 | pEC50 | >100000 | nM | EC50 | ACS Med Chem Lett (2012) 3: 273-277 [PMID:24900463] |
ChEMBL | Agonist activity at glutathione transferase-tagged human FXR-LBD using biotinylated Src-1 peptide incubated for 30 mins by recruitment coactivator assay | B | 4 | pEC50 | >100000 | nM | EC50 | J Med Chem (2016) 59: 9201-9214 [PMID:27652492] |
ChEMBL | Agonist activity at glutathione transferase-tagged human FXR ligand binding domain assessed as biotinylated Src1 peptide recruitment incubated for 30 mins by AlphaScreen assay | B | 4 | pEC50 | >100000 | nM | EC50 | Eur J Med Chem (2022) 242: 114652-114652 [PMID:36049273] |
ChEMBL | Activation of GST-tagged FXR LBD (unknown origin) using biotinylated Src-1 peptide as substrate by AlphaScreen assay | B | 4 | pEC50 | >100000 | nM | EC50 | Eur J Med Chem (2023) 261: 115851-115851 [PMID:37813065] |
GPBA receptor/G-protein coupled bile acid receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5409] [GtoPdb: 37] [UniProtKB: Q8TDU6] | ||||||||
ChEMBL | Agonist activity at GPBAR1 in human NCI-H716 cells assessed as stimulation of cAMP production | F | 4.89 | pEC50 | 13000 | nM | EC50 | Bioorg Med Chem Lett (2013) 23: 4627-4632 [PMID:23831134] |
ChEMBL | Agonist activity at human TGR5 expressed in uninduced Flp-In-CHO-TO cells assessed as increase in intracellular cAMP measured after 48 hrs by HTRF competitive immunoassay | F | 5.26 | pEC50 | 5540 | nM | EC50 | ACS Med Chem Lett (2013) 4: 63-68 [PMID:24900564] |
ChEMBL | Agonist activity at human TGR5 expressed in CHO cells assessed as increase in CRE-driven gene expression by luciferase reporter gene assay | F | 5.46 | pEC50 | 3440 | nM | EC50 | J Med Chem (2009) 52: 7958-7961 [PMID:20014870] |
ChEMBL | Agonist activity at human TGR5 expressed in human HEK293 cells co-expressing CRE-driven luciferase reporter gene assessed as luciferase activity incubated for 5.5 hrs by Steady-Glo based luciferase assay | F | 5.62 | pEC50 | 2423 | nM | EC50 | Eur J Med Chem (2022) 242: 114697-114697 [PMID:36029562] |
ChEMBL | Agonist activity at human TGR5 expressed in HEK293 cells assessed CRE-induced luciferase activity after 5.5 hrs by reporter gene assay | F | 5.91 | pEC50 | 1230 | nM | EC50 | Eur J Med Chem (2013) 69: 55-68 [PMID:24007860] |
ChEMBL | Agonist activity at human TGR5 expressed in HEK293 cells assessed as CRE-driven luciferase reporter gene activity incubated for 5.5 hrs and measured by Steady Glow reagent based luminescence assay | F | 6 | pEC50 | 1004 | nM | EC50 | Eur J Med Chem (2020) 203: 112619-112619 [PMID:32682201] |
ChEMBL | Agonist activity at TGR5 receptor in human NCI-H716 cells assessed as activation of intracellular cAMP production incubated for 1 hr by HTR-FRET assay | F | 6.05 | pEC50 | 900 | nM | EC50 | Eur J Med Chem (2022) 242: 114652-114652 [PMID:36049273] |
ChEMBL | Agonist activity at TGR5 in human NCI-H716 cells assessed as stimulation of intracellular cAMP accumulation incubated for 60 mins by HTR-FRET assay | F | 6.05 | pEC50 | 900 | nM | EC50 | J Med Chem (2016) 59: 9201-9214 [PMID:27652492] |
ChEMBL | Agonist activity at TGR5 in human NCI-H716 cells assessed as increase in cAMP level incubated for 60 mins by HTR-FRET assay | F | 6.07 | pEC50 | 850 | nM | EC50 | Eur J Med Chem (2023) 261: 115851-115851 [PMID:37813065] |
ChEMBL | Agonist activity at TGR5 expressed in NCI-H716 cells assessed as cAMP level after 60 mins by FRET analysis | F | 6.09 | pEC50 | 820 | nM | EC50 | ACS Med Chem Lett (2012) 3: 273-277 [PMID:24900463] |
ChEMBL | Agonist activity at human TGR5 transfected in HEK293T cells assessed intracellular cAMP level by HTRF assay | F | 6.09 | pEC50 | 820 | nM | EC50 | Bioorg Med Chem (2021) 32: 115972-115972 [PMID:33440321] |
ChEMBL | Agonist activity at human TGR5 expressed in HEK293 cells assessed as cAMP level after 48 hrs by fluorescent assay | F | 6.53 | pEC50 | 293 | nM | EC50 | Bioorg Med Chem Lett (2014) 24: 4271-4275 [PMID:25082126] |
ChEMBL | Agonist activity at wild type TGR5 (unknown origin) | B | 6.74 | pEC50 | 180 | nM | EC50 | ACS Med Chem Lett (2013) 4: 1158-1162 [PMID:24900622] |
ChEMBL | Agonist activity at human TGR5 expressed in deoxycycline-induced Flp-In-CHO-TO cells assessed as increase in intracellular cAMP measured after 48 hrs by HTRF competitive immunoassay | F | 6.78 | pEC50 | 166 | nM | EC50 | ACS Med Chem Lett (2013) 4: 63-68 [PMID:24900564] |
GPBA receptor/G-protein coupled bile acid receptor 1 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1255150] [GtoPdb: 37] [UniProtKB: Q80SS6] | ||||||||
GtoPdb | - | - | 6.09 | pEC50 | - | - | - | J Med Chem (2009) 52: 7958-61 [PMID:20014870] |
ChEMBL | Agonist activity at mouse TGR5 expressed in human HEK293 cells co-expressing CRE-driven luciferase reporter gene assessed as luciferase activity incubated for 5.5 hrs by Steady-Glo based luciferase assay | F | 6.23 | pEC50 | 586 | nM | EC50 | Eur J Med Chem (2022) 242: 114697-114697 [PMID:36029562] |
ChEMBL | Agonist activity at mouse TGR5 expressed in HEK293 cells assessed CRE-induced luciferase activity after 5.5 hrs by reporter gene assay | F | 6.44 | pEC50 | 360 | nM | EC50 | Eur J Med Chem (2013) 69: 55-68 [PMID:24007860] |
ChEMBL | Agonist activity at mouse TGR5 expressed in HEK293 cells assessed as CRE-driven luciferase reporter incubated for 5.5 hrs and measured by Steady Glow reagent based luminescence assay | F | 6.6 | pEC50 | 251 | nM | EC50 | Eur J Med Chem (2020) 203: 112619-112619 [PMID:32682201] |
ChEMBL | Agonist activity at mouse TGR5 transfected in HEK293T cells assessed intracellular cAMP level by HTRF assay | F | 6.88 | pEC50 | 132 | nM | EC50 | Bioorg Med Chem (2021) 32: 115972-115972 [PMID:33440321] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]